CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy, and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02189252
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:11.929232+00:00
Published At: 2016-06-20T00:00:00+00:00
Record Updated At: 2016-06-20
Results Posted At: 2016-06-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Severe Hypertriglyceridemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-06-20"
protocolSection.identificationModule.nctId: "NCT02189252"
protocolSection.identificationModule.officialTitle: "A Randomized, Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy, and Safety of Epanova\u00ae and Lovaza\u00ae in Men and Women With a History of Pancreatitis"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2016-06-20"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.